Medication info
Atorva 20 mg Tablet (Atorvastatin Calcium Trihydrate)

Atorva 20 mg Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet경구
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
(주)서울제약
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201310004 · Approved 2013.11.01 · Insurance code 652903400

Summary

Main use
Reduction of the risk of myocardial infarction and stroke, improvement of hypercholesterolemia
Who takes it
Adults · Children
Adult dose
The recommended initial dose for hyperlipidemia is 10 mg of atorvastatin once daily; if more LDL cholesterol reduction is required, treatment may begin with 20 mg or 40 mg once daily. The medication is administered in a dosage range of 10 to 80 mg once daily. Dosing should be individualized based on treatment goals and responses, with lipid levels analyzed and dosages adjusted within 2 to 4 weeks. The treatment goal is to lower LDL cholesterol levels, so monitoring LDL cholesterol levels is recommended during treatment initiation and response evaluation. If LDL cholesterol levels cannot be monitored, total cholesterol levels should be used to evaluate treatment response. For patients with homozygous familial hypercholesterolemia, the dosing is 10 to 80 mg once daily, either in combination with other lipid-lowering therapies (e.g., LDL apheresis) or when such therapies are not possible. For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the recommended initial dose of this medication is 10 mg once daily, with a maximum recommended dose of 20 mg once daily (no clinical data are available for doses higher than 20 mg in pediatric patient groups). The dose should be appropriately adjusted according to the recommended treatment goals for individual patients, with adjustments made at intervals of 4 weeks or more. ○ Patients with renal impairment: Renal conditions do not affect atorvastatin plasma concentrations or LDL cholesterol-lowering effects, so dose adjustment is not necessary. ○ Elderly patients: The effectiveness and safety for elderly patients (over 70 years old) are similar to those for the general adult patient population.
Child dose
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the recommended initial dose is 10 mg once daily, with a maximum dose of 20 mg once daily. The dosage should be adjusted at intervals of 4 weeks or more.

Ingredients

Manufacturer
(주)서울제약

Efficacy & effects

Reduction of the risk of myocardial infarction and stroke, improvement of hypercholesterolemia

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular reconstruction
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hyperlipidemia
  • hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction and stroke, as well as the risk of heart-related issues such as vascular reconstruction or angina. It is also effective for diabetes patients or those with multiple risk factors. Additionally, it improves cholesterol and triglyceride levels in patients with primary hypercholesterolemia and dyslipidemia, and aids in increasing HDL cholesterol. This medication is used as an adjunct treatment to lower cholesterol levels in pediatric patients with familial hypercholesterolemia. Overall, it is used to improve heart and vascular health.

How to take

Adult dose

The recommended initial dose for hyperlipidemia is 10 mg of atorvastatin once daily; if more LDL cholesterol reduction is required, treatment may begin with 20 mg or 40 mg once daily. The medication is administered in a dosage range of 10 to 80 mg once daily. Dosing should be individualized based on treatment goals and responses, with lipid levels analyzed and dosages adjusted within 2 to 4 weeks. The treatment goal is to lower LDL cholesterol levels, so monitoring LDL cholesterol levels is recommended during treatment initiation and response evaluation. If LDL cholesterol levels cannot be monitored, total cholesterol levels should be used to evaluate treatment response. For patients with homozygous familial hypercholesterolemia, the dosing is 10 to 80 mg once daily, either in combination with other lipid-lowering therapies (e.g., LDL apheresis) or when such therapies are not possible. For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the recommended initial dose of this medication is 10 mg once daily, with a maximum recommended dose of 20 mg once daily (no clinical data are available for doses higher than 20 mg in pediatric patient groups). The dose should be appropriately adjusted according to the recommended treatment goals for individual patients, with adjustments made at intervals of 4 weeks or more. ○ Patients with renal impairment: Renal conditions do not affect atorvastatin plasma concentrations or LDL cholesterol-lowering effects, so dose adjustment is not necessary. ○ Elderly patients: The effectiveness and safety for elderly patients (over 70 years old) are similar to those for the general adult patient population.

Child dose

For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the recommended initial dose is 10 mg once daily, with a maximum dose of 20 mg once daily. The dosage should be adjusted at intervals of 4 weeks or more.

Precautions

This medication should be discontinued immediately and a doctor consulted if any unusual muscle symptoms occur. Particular caution is needed if severe muscle pain, weakness, or cramps develop. This medication should not be used in patients with poor liver function or liver diseases, and regular liver function tests should be conducted. If symptoms of hepatitis or jaundice occur, medical personnel should be informed immediately. This medication should not be taken by women who are pregnant or may become pregnant, and by breastfeeding women. Women of childbearing potential should use appropriate contraception while taking this medication. This medication is not to be given to children under 10 years old or patients with specific genetic lactose intolerance disorders. As this medication has many drug interactions, it is crucial to consult with a doctor or pharmacist when taking it with certain antibiotics, antifungal agents, HIV treatments, and some antihypertensive medications. Elderly patients or those with reduced kidney function should be observed more closely due to an increased risk of muscle-related side effects while taking this medication. If symptoms such as muscle pain, weakness, or fever occur while taking this medication, the doctor should be informed immediately, and a blood test should be conducted. If significantly elevated serum creatine kinase levels are found, the medication should be discontinued. Taking this medication with grapefruit juice may increase blood concentration, increasing the risk of side effects, so it is advisable to avoid grapefruit juice. It is preferable to refrain from alcohol consumption during treatment and to undergo periodic liver function tests for liver health.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rashes accompanied by high fever, blisters, skin peeling, pain in oral or eye mucosa, shortness of breath or difficulty breathing, asthma attacks, breathing difficulties accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

  • Weakness
  • fatigue
  • chest pain
  • peripheral edema
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • loss of appetite
Show 26 more
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • sensory abnormalities
  • sensory loss
  • taste abnormalities
  • memory loss
  • peripheral neuropathy
  • muscle pain
  • joint pain
  • pain in limbs
  • musculoskeletal pain
  • muscle cramps
  • joints

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 to 30 degrees Celsius room temperature. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.